Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study

Detalles Bibliográficos
Autores principales: Bain, Stephen C, Carstensen, Bendix, Hyveled, Liselotte, Seremetis, Stephanie, Flindt Kreiner, Frederik, Amadid, Hanan, Clark, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277078/
https://www.ncbi.nlm.nih.gov/pubmed/37328273
http://dx.doi.org/10.1136/bmjdrc-2022-003300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277078/
https://www.ncbi.nlm.nih.gov/pubmed/37328273
http://dx.doi.org/10.1136/bmjdrc-2022-003300

Ejemplares similares